Compare NMZ & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMZ | CRON |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | N/A |
| Metric | NMZ | CRON |
|---|---|---|
| Price | $10.62 | $2.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 356.8K | ★ 1.5M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $132,357,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | N/A | $30.76 |
| P/E Ratio | ★ N/A | $27.83 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $8.26 | $1.60 |
| 52 Week High | $11.14 | $3.43 |
| Indicator | NMZ | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 53.74 |
| Support Level | $10.50 | $2.54 |
| Resistance Level | $10.57 | $2.63 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 90.48 | 66.28 |
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.